Method of analyzing for at least one allergy

(19)

(11)

EP 2 335 598 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	05.10.2016 Bulletin 2016/40

(45)	Mention of the grant of the patent:
	06.07.2016 Bulletin 2016/27

(21)	Application number: 11154288.2

(22)	Date of filing: 14.12.2007

(51)

International Patent Classification (IPC):

A61B 10/00^(2006.01)

G01N 33/68^(2006.01)

(54)	Method of analyzing for at least one allergy Verfahren zur Analyse mindestens einer Allergie Procédé pour l'analyse d'au moins une allergie

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

(30)

Priority:

21.12.2006 US 876452 P

(43)	Date of publication of application:
	22.06.2011 Bulletin 2011/25

(62)	Application number of the earlier application in accordance with Art. 76 EPC:
	07024260.7 / 1935347

(73)	Proprietor: Ascensia Diabetes Care Holdings AG
	4052 Basel (CH)

(72)	Inventor:
	Rebec, Mihailo V. Bristol, IN 46507 (US)

(74)	Representative: Cohausz & Florack
	Patent- & Rechtsanwälte Partnerschaftsgesellschaft mbB Postfach 10 18 30 40009 Düsseldorf 40009 Düsseldorf (DE)

(56)

References cited: :

WO-A-99/25826
WO-A-2007/008800
US-A- 5 335 670
US-A- 5 897 506

WO-A-02/076477
US-A- 4 819 657
US-A- 5 874 226
US-A- 5 944 662

MCBRIDE P ET AL: "Use of plasma histamine levels to monitor cutaneous mast cell degranulation.", THE JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY FEB 1989, vol. 83, no. 2 Pt 1, February 1989 (1989-02), pages 374-380, XP002475419, ISSN: 0091-6749

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).